Subscribe to Newsletter

Search

Reset Filter

4254 search results for ‘*’

Business & Regulation Standards & Regulation

The Future of the NIH

| Hernan Bazan | 2 min read

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

Discovery & Development Drug Discovery

The Glycomic Revolution

| 2 min read

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Manufacture Advanced Medicine

Building a Resilient CGT Workforce

| Daniel Palmacci | 3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Manufacture Quality & Compliance

Innovating Pharmaceutical Packaging

| 3 min read

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements

Business & Regulation Business Practice

Calling Out Misleading Information

| Rob Coker | 2 min read

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

Business & Regulation Advanced Medicine

We Need to Talk About CRISPR

| 4 min read

Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.

Manufacture Technology and Equipment

The Myths and Reality of Hot Melt Extrusion

| Hibreniguss Terefe, Shahab Kashani Rahimi | 6 min read

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

Business & Regulation Digital Technologies

Forecasting Medicine Use and Controlling Supply Chains

| Tim Tinnel | 3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

Business & Regulation Standards & Regulation

GSK’s Flovent Strategy Under Federal Scrutiny?

| Rob Coker | 2 min read

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Discovery & Development Drug Discovery

Hail to the Hardy Tardigrade

| Rob Coker | 2 min read

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register